| Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983, 2019 | 411 | 2019 |
| Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019 | 332 | 2019 |
| Safety of combining radiotherapy with immune-checkpoint inhibition WL Hwang, LRG Pike, TJ Royce, BA Mahal, JS Loeffler Nature reviews Clinical oncology 15 (8), 477-494, 2018 | 266 | 2018 |
| Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015 BA Mahal, S Butler, I Franco, DE Spratt, TR Rebbeck, AV D’Amico, ... Jama 321 (7), 704-706, 2019 | 236 | 2019 |
| Integrated analysis of genetic ancestry and genomic alterations across cancers J Yuan, Z Hu, BA Mahal, SD Zhao, KH Kensler, J Pi, X Hu, Y Zhang, ... Cancer cell 34 (4), 549-560. e9, 2018 | 221 | 2018 |
| Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States BA Mahal, PJ Catalano, RI Haddad, GJ Hanna, JI Kass, JD Schoenfeld, ... Cancer Epidemiology, Biomarkers & Prevention 28 (10), 1660-1667, 2019 | 202 | 2019 |
| Prostate cancer radiation therapy recommendations in response to COVID-19 NG Zaorsky, BY James, SM McBride, RT Dess, WC Jackson, BA Mahal, ... Advances in radiation oncology 5, 26-32, 2020 | 185 | 2020 |
| The Lancet Commission on prostate cancer: planning for the surge in cases ND James, I Tannock, J N'Dow, F Feng, S Gillessen, SA Ali, B Trujillo, ... The Lancet 403 (10437), 1683-1722, 2024 | 183 | 2024 |
| Marital status and head and neck cancer outcomes G Inverso, BA Mahal, AA Aizer, RB Donoff, NG Chau, RI Haddad Cancer 121 (8), 1273-1278, 2015 | 170 | 2015 |
| Association of androgen deprivation therapy with depression in localized prostate cancer KT Dinh, G Reznor, V Muralidhar, BA Mahal, MD Nezolosky, TK Choueiri, ... Journal of Clinical Oncology 34 (16), 1905-1912, 2016 | 162 | 2016 |
| A systematic review of the evidence for the decipher genomic classifier in prostate cancer NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ... European urology 79 (3), 374-383, 2021 | 160 | 2021 |
| The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors LRG Pike, A Bang, BA Mahal, A Taylor, M Krishnan, A Spektor, ... International Journal of Radiation Oncology* Biology* Physics 103 (1), 142-151, 2019 | 154 | 2019 |
| Prostate cancer–specific mortality across Gleason scores in black vs nonblack men BA Mahal, RA Berman, ME Taplin, FW Huang Jama 320 (23), 2479-2481, 2018 | 151 | 2018 |
| Racial disparities in B lack men with prostate cancer: A literature review JW Lillard Jr, KA Moses, BA Mahal, DJ George Cancer 128 (21), 3787-3795, 2022 | 149 | 2022 |
| Incidence and predictors of upgrading and up staging among 10,000 contemporary patients with low risk prostate cancer KT Dinh, BA Mahal, DR Ziehr, V Muralidhar, YW Chen, VB Viswanathan, ... The Journal of urology 194 (2), 343-349, 2015 | 144 | 2015 |
| Racial differences in genomic profiling of prostate cancer BA Mahal, M Alshalalfa, KH Kensler, I Chowdhury-Paulino, P Kantoff, ... New England Journal of Medicine 383 (11), 1083-1085, 2020 | 113 | 2020 |
| Clinical and genomic characterization of low–prostate-specific antigen, high-grade prostate cancer BA Mahal, DD Yang, NQ Wang, M Alshalalfa, E Davicioni, V Choeurng, ... European urology 74 (2), 146-154, 2018 | 107 | 2018 |
| Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis LA Gharzai, R Jiang, D Wallington, G Jones, S Birer, N Jairath, ... The Lancet Oncology 22 (3), 402-410, 2021 | 105 | 2021 |
| Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer DE Spratt, M Alshalalfa, N Fishbane, AB Weiner, R Mehra, BA Mahal, ... Clinical Cancer Research 25 (22), 6721-6730, 2019 | 100 | 2019 |
| Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European journal of cancer 185, 178-215, 2023 | 98 | 2023 |
Paul L NguyenProfessor of Radiation Oncology, Dana-Farber/Brigham and Women's, Harvard Medical SchoolLROC.harvard.edu의 이메일 확인됨